Markets HCW ups Celldex Therapeutics PT to $25 from $16 H.C Wainwright raised its price target for Celldex Therapeutics (NASDAQ:CLDX) to $25 from $16, citing three differentiated programs that are now in the clinic. The stock closed at $15.76 on Oct. 16. “As we have stated... October 19, 2020